Insulin-like growth factor-I induces chemoresistence to docetaxel by inhibiting miR-143 in human prostate cancer

Elevated levels of insulin-like growth factor-I (IGF-I) are associated with carcinogenesis and cancer progression. However, the molecular mechanisms by which IGF-I promotes prostate cancer development remain to be elucidated. Docetaxel chemotherapy is an important therapeutic strategy in many types...

Descripción completa

Detalles Bibliográficos
Autores principales: Niu, Xiao-Bing, Fu, Guang-Bo, Wang, Lin, Ge, Xin, Liu, Wei-Tao, Wen, Yi-Yang, Sun, Hao-Ran, Liu, Ling-Zhi, Wang, Zeng-Jun, Jiang, Bing-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739804/
https://www.ncbi.nlm.nih.gov/pubmed/29291019
http://dx.doi.org/10.18632/oncotarget.22362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739804/
https://www.ncbi.nlm.nih.gov/pubmed/29291019
http://dx.doi.org/10.18632/oncotarget.22362

Ejemplares similares